This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Colgate (CL) Stock Down 14.3% YTD: What You Should Know
by Zacks Equity Research
Colgate's (CL) dismal performance can be attributed to uncertain global markets. Also, a dismal sales trend is worrisome. However, the company's savings programs appear impressive.
Bear of the Day: Colgate-Palmolive (CL)
by Madeleine Johnson
Earnings estimated have fallen sharply for this consumer staples giant.
New Strong Sell Stocks for November 27th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Why Is Colgate-Palmolive (CL) Down 3.2% Since Last Earnings Report?
by Zacks Equity Research
Colgate-Palmolive (CL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
New Strong Sell Stocks for October 31st
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Company News For Oct 29, 2018
by Zacks Equity Research
Companies In The News Are: GOOGL, INTC, CL, CMG
Imports Boost Q3 GDP
by Zacks Equity Research
Imports Boost Q3 GDP
Q3 GDP Reaches 3.5% on Big Import Growth
by Mark Vickery
3.5% Q3 GDP on the headline was better by 20-30 basis points from analyst consensus, though lower than Q2's unrevised 4.2% growth in the June quarter.
Colgate's (CL) Q3 Earnings In Line, Sales Miss Estimates
by Zacks Equity Research
Colgate (CL) posts in-line earnings in third-quarter 2018 with a top line miss. Also, it expects a challenging backdrop moving ahead.
Colgate-Palmolive (CL) Q3 Earnings Meet Estimates
by Zacks Equity Research
Colgate-Palmolive (CL) delivered earnings and revenue surprises of 0.00% and -0.81%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Things You Need to Know Before Colgate's (CL) Q3 Earnings
by Zacks Equity Research
Colgate (CL) is progressing well with its Global Growth and Efficiency Program. However, it witnesses strained margins due to higher raw material and packaging costs.
Colgate-Palmolive (CL) Q3 Earnings Preview: What to Look Out For
by Zacks Equity Research
Colgate-Palmolive (CL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Soap & Cleaning Materials Stock Outlook: Near-Term Picture Drab
by Zacks Equity Research
Intense competition as well as increased raw material, transportation and packaging costs are impacting Soap and Cleaning Materials industry, resulting in bleak near-term prospects.
New Strong Sell Stocks for August 1st
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Market News For Jul 30, 2018
by Zacks Equity Research
Companies in the news are: CL, SBUX, SAM and EXPE
Colgate's (CL) Q2 Earnings In Line With Estimates, Sales Lag
by Zacks Equity Research
Colgate (CL) delivers first-quarter 2018 earnings in line with the Zacks Consensus Estimate but its sales lag. However, both the top and bottom line improves year over year.
Colgate (CL) Q2 Earnings In Line, Sales Miss, Stock Down
by Zacks Equity Research
Colgate (CL) came out with second-quarter 2018 results, wherein it recorded adjusted earnings of 77 cents per share, which came in line with the Zacks Consensus Estimate.
Will Robust Strategies Fuel Colgate's (CL) Q2 Earnings?
by Zacks Equity Research
Colgate (CL) is encouraged with its savings program along with brand building and productivity maximization initiatives. These, in turn, are likely to drive second-quarter 2018 results.
Trade War Tensions Re-escalate
by Zacks Equity Research
Trade War Tensions Re-escalate
Trade War Rhetoric Heats Up
by Mark Vickery
We "celebrate" Independence Day week, not to mention the first trading day of the second half of the calendar year, re-stoking the fires of a global trade war.
Can Colgate's (CL) Growth Strategies Help Regain Momentum?
by Zacks Equity Research
Colgate's (CL) long-term strategies and earnings trend reflect fundamental strength, positioning it for growth. However, soft-margin trend remains a deterrent.
Implied Volatility Surging for Colgate-Palmolive (CL) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Colgate-Palmolive (CL) stock based on the movements in the options market lately.
Colgate-Palmolive (CL) Down 6.2% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Colgate-Palmolive (CL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Buyouts & More to Fuel Church & Dwight (CHD) in Q1 Earnings
by Zacks Equity Research
Church & Dwight (CHD) is set to gain from its robust international presence, organic sales trend and focus on buyouts. However, the company remains troubled by commodity and transportation costs.
Colgate (CL) Q1 Earnings Top, Sales Lag Estimates, Stock Down
by Zacks Equity Research
Colgate (CL) came out with first-quarter 2018 results, wherein adjusted earnings of 74 cents per share outpaced the Zacks Consensus Estimate of 73 cents.